Start for free
Start for free
MA

Madison Avenue Partners

North America, New York, United States, New York

Description

Madison Avenue Partners is an investment firm.

Investor Profile

Madison Avenue Partners has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Genetics
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Madison Avenue Partners frequently co-invest with?

EcoR1 Capital
EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 3
Nantahala Capital Management
Nantahala Capital Management
North America, Connecticut, United States, New Canaan
Co-Investments: 1
Farallon Capital Management
Farallon Capital Management
North America, California, United States, San Francisco
Co-Investments: 1
New Enterprise Associates
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 2
Octagon Capital Advisors
Octagon Capital Advisors
North America, New York, United States, New York
Co-Investments: 1
Rock Springs Capital
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 2
Armistice Capital
Armistice Capital
North America, New York, United States, New York
Co-Investments: 2
Invus
Invus
North America, New York, United States, New York
Co-Investments: 2
FK
Federated Kaufmann Fund
North America, Pennsylvania, United States, Pittsburgh
Co-Investments: 1
Boxer Capital
Boxer Capital
North America, Florida, United States, Windermere
Co-Investments: 3

What are some of recent deals done by Madison Avenue Partners?

Gossamer Bio

San Diego, California, United States

Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityJul 20, 2023
Amount Raised: $212,000,000
Gossamer Bio

San Diego, California, United States

Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityJul 13, 2022
Amount Raised: $120,000,000
2seventy bio

Cambridge, Massachusetts, United States

2seventy bio is an immuno-oncology cell therapy company that discovers and develops cancer therapies.

BiotechnologyGeneticsHealth CareOncologyTherapeutics
Post Ipo EquityMar 16, 2022
Amount Raised: $170,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator